SINOVA-M-14030 Testosterone Quantitative Test Kit

Clinical Significance:
Increased Levels: Observed in idiopathic male precocious puberty, familial male precocious puberty, adrenal cortex hyperplasia, adrenal cortex tumors (marked increase in adenocarcinoma, common increase in adenoma), testicular tumors, testicular feminization, polycystic ovary syndrome, ovarian masculinizing tumors, pineal tumors, idiopathic hirsutism, hypothyroidism, androgen, HCG, and estrogen treatments.
Decreased Levels: Observed in Down syndrome, uremia, myotonic dystrophy, liver insufficiency, cryptorchidism, primary or secondary gonadal insufficiency (e.g., Klinefelter syndrome, Kallmann syndrome), after discontinuation of androgen treatment. Decreased testosterone is also seen in male hypogonadism, eunuchoid syndrome, hypothalamic or pituitary gonadal insufficiency, hyperthyroidism, liver cirrhosis, renal failure, severe trauma, and chronic debilitating diseases.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
 
Usage Scenarios:
Hospitals and Clinics: For diagnosing and monitoring conditions related to abnormal testosterone levels, such as precocious puberty, adrenal cortex tumors, testicular tumors, polycystic ovary syndrome (PCOS), and gonadal insufficiency.
Endocrinology Departments: To assess hormonal imbalances and manage treatment for conditions affecting testosterone levels.
Diagnostic Laboratories: For routine testing of testosterone levels in various clinical conditions.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc.
Global Health Programs: International health initiatives focusing on reproductive health and endocrine disorders in low-resource settings.